Whilst cross-presentation remained effective in late stage tumour growth, direct presentation occurring in TDLN containing metastases resulted in incomplete CD8+ T cell differentiation which was likely due to tumour mediated immunosuppressive changes to APCs and the TME. The gene discussed is CD8A; the disease is neoplasm.